The fundamental goal of hepatitis C treatment is to completely remove the hepatitis C virus from the body, which is still difficult to achieve. Instead, it is possible to achieve maximum suppression of viral replication, delay and reduce liver damage, try to avoid the development of cirrhosis, and improve the patient’s quality of life. Hepatitis C is an infectious disease that causes inflammatory necrosis and fibrosis of the liver due to infection with the hepatitis C virus, and some patients with hepatitis C can develop cirrhosis or even liver cancer, which shows how threatening this disease is to the health of patients. The treatment of hepatitis C should be based on the following principles: Combination therapy, treating both the symptoms and the root cause of hepatitis C. The fundamental goal of hepatitis C treatment is to completely remove the hepatitis C virus from the body, which is still difficult to achieve. However, it is possible to achieve the goal of maximally inhibiting viral replication, delaying and reducing liver damage, avoiding the development of cirrhosis, and improving the patient’s quality of life. At present, the treatment of hepatitis C mostly takes the combination of antiviral therapy (treatment of the root cause), and at the same time adjuvant hepatoprotective agents to restore liver function (treatment of the symptoms). Antiviral therapy has undergone a transition from alpha-interferon to pegylated interferon, and now pegylated interferon combined with ribavirin has become the antiviral regimen with the best efficacy. If the right drug is used, an antiviral response effect can be achieved in 3/4 of patients. For hepatitis C patients with abnormal liver function, they can also use some liver-protective drugs, such as glycine and hepatitis luciferin, which can promote liver cell regeneration and reduce the inflammatory response of the liver. The use of antiviral combination therapy regimens is not suitable for everyone, but rather the indications must be strictly controlled. Only when the indications for treatment are met can satisfactory results be achieved. The following indications should be present for the use of antiviral combination therapy: recurrent elevation of transaminases, or liver histology suggesting significant inflammatory necrosis or moderate or above liver fibrosis. Antiviral therapy should also be given if liver function tests are normal, but liver histology suggests inflammatory activity and significant liver fibrosis. Patients with early cirrhosis (compensated cirrhosis) can be treated with antiviral therapy under close observation. In principle, antiviral therapy should also be given to pediatric and elderly patients with hepatitis C. However, the patient’s condition should be treated differently, and the target of treatment should preferably be well-tolerated by the drug and free of other co-morbidities (e.g. hypertension, coronary heart disease, etc.). For patients with alcohol and drug abuse, they should first stop drinking and smoking, and then give treatment afterwards. Interferon therapy is contraindicated in those with renal dysfunction. Patients need to be genotyped and quantitatively tested for hepatitis C virus before receiving antiviral therapy, as different viral genotypes, different viral loads, and different drug doses and regimens are used. Although pegylated interferon combined with ribavirin is more effective in treating hepatitis C, it takes 48 weeks of treatment and costs more than $60,000 to treat, so it is important that patients have the financial means to complete the entire treatment. If a patient cannot afford to pay such high treatment costs, he or she can settle for the second-best option of generic alpha-interferon combined with ribavirin, which will be much less expensive, but also less effective. As pegylated interferon combined with ribavirin treatment lasts up to 48 weeks, the patient’s compliance is very important as the treatment has to be followed up for years afterwards with regular liver function, viral indicators and ultrasound, etc. Before treatment, the entire treatment plan needs to be clearly explained to the patient, the patient’s compliance needs to be assessed, and it is very important to have a comprehensive understanding of the patient’s background material, including the patient’s psychological, economic and family situations, so as to reasonably This includes the patient’s psychological, economic, family and other conditions, so that the treatment plan can be formulated reasonably to ensure the desired effect of the treatment. The doctor must explain to the patient the natural course of the disease and the need for treatment, the purpose of antiviral therapy, the possible level of treatment and the success rate, especially the adverse effects of drug therapy and the prevention and response methods, and be clear about the benefits and risks of treatment. The potential benefits and risks of treatment. For long-term and expensive antiviral treatment, patients need to sign an informed consent form with the hospital, in which both the doctor and the patient share the responsibility and liability for the treatment. Expert guidance is needed throughout the treatment process. For some problems that may occur during the treatment, such as interferon can cause many adverse reactions, like cold syndrome, bone marrow suppression, etc., doctors must take appropriate measures. Pay attention to the life points and cooperate with the treatment scientifically Female patients should take contraceptive measures while receiving antiviral treatment. Pregnancy should be considered only after six months after the cessation of treatment, when the patient’s liver function is always normal. Patients with hepatitis C have iron excretion disorders, and the accumulation of excess iron in the body is harmful and resists the antiviral effects of interferon. Therefore, patients with hepatitis C should limit foods high in iron, such as animal liver, and avoid using iron cookware. Alcohol is a big no-no in liver disease, and people with hepatitis C should first stop drinking. They should also avoid exposure to harmful chemicals and eat less food with too many colors and preservatives. Use drugs that are hepatotoxic with caution when you are sick. Patients should eat less fat and sugar in their diet to reduce the burden on the liver. Patients should eat light and easily digestible foods, such as vegetables, fruits, soy products, fish, etc. Chinese and western medicine combine to take advantage of the unique efficacy of Chinese medicinal preparations in protecting the liver and restoring liver function. In recent years, Chinese medicinal preparations have made breakthroughs in anti-liver fibrosis, and some of them have been proven to inhibit liver fibrous tissue proliferation, reduce fibroblast activity, lower portal hypertension and improve intrahepatic microcirculation. The correct and rational use of these herbal preparations can assist in improving the efficacy and inhibiting the adverse effects of antiviral drugs.